Search results
Added:
2 years ago
Source:
EchoNous
A portable heart scanner which uses breakthrough artificial intelligence is solving reproducibility and repeatability issues in echocardiography, enabling clinicians to diagnose heart failure more quickly whilst also shortening exam times.
Renowned cardiologists say that as well as helping to save time - enabling them to see more patients and reducing waiting times - it tackles the long…
View more
THT 2024
Start date:
Mar 06, 2024
End date:
Mar 04, 2024
Event
Author(s):
Praveen Chandra
Added:
1 year ago
In this short interview, Dr Praveen Chandra (Medanta - The Medicity, IN) shares key findings from the study that looked at the sirolimus-coated balloon with micro-reservoir technology in coronary lesions. The study investigated the SELUTION SLR drug-eluting balloon (MedAlliance) for coronary and peripheral indications.
Discussion Points:
1. Study Rationale
2. Micro-reservoir Technology
3. Study…
View more
Author(s):
Evan Chong
,
Roberto De Ponti
Added:
3 years ago
CathRx was founded in Australia over 10 years ago with the goal of designing better medical devices. With a strong background in the pacing/defibrillator industry, its initial focus has been on electrophysiology catheters. These devices have been used for over 40 years, with little change in their fundamental design and construction. Considering the tremendous advances in understanding and…
View more
Author(s):
Dariusz Dudek
,
Jacek Legutko
,
Roman Wojdyła
,
et al
Added:
3 years ago
Thrombectomy for patients with ST elevation myocardial infarction (STEMI) is an evolving issue. Randomised studies on suction and thrombectomy devices in a whole spectrum of STEMI patients provide conflicting results. New European Society of Cardiology (ESC) percutaneous coronary intervention (PCI) guidelines do not give definitive recommendations regarding the use of embolic protection devices…
View more
Author(s):
Dariusz Dudek
,
Jacek Legutko
,
Roman Wojdyła
,
et al
Added:
3 years ago
Thrombectomy for patients with ST elevation myocardial infarction (STEMI) is an evolving issue. Randomised studies on suction and thrombectomy devices in a whole spectrum of STEMI patients provide conflicting results. New European Society of Cardiology (ESC) percutaneous coronary intervention (PCI) guidelines do not give definitive recommendations regarding the use of embolic protection devices…
View more
AHA 23: The ORFAN Study
Author(s):
Charalambos Antoniades
Added:
4 months ago
Video
Author(s):
William T Abraham
Added:
1 year ago
HFSA 2022 — Dr William T Abraham (The Ohio State University, US) talks about a study assessing a remote speech analysis application, Cordio app (Cordio Medical) that evaluated hospitalized patients with acute decompensated heart failure (NCT03266029).
Questions
What is the background of this study?
What is the Cordio app and what is the premise behind the HearO System?
What is the study design…
View more
Author(s):
Jose Luis Zamorano
Added:
3 years ago
The clinical and economic impact of heart failure (HF) is well documented. It affects 22 million people worldwide, occurs in at least 2% of the Western adult population and is a progressive condition with high morbidity and mortality rates, placing a significant burden on healthcare resources.3 One of the keys to reducing the clinical and economic impact of HF is accurate and early diagnosis of…
View more
Author(s):
Hector M Garcia-Garcia
Added:
2 years ago
In this video from CRT 2022's late-breaking trials, Dr Hector M Garcia-Garcia (MedStar Washington Hospital Center, Washington DC, US) discusses the technology behind the hands-free AutocathFFR System, an AI-based method of angiography imaging-derived FFR Technology for coronary artery disease revascularization. Dr Garcia-Garcia reveals that the outcomes of Angiographic-derived FFR were comparable…
View more